Research Management Group (RMG)

The Dana Foundation
David Mahoney Neuroimaging Program:
Using Brain and Immune Imaging to Improve Human Health

**Limited funding opportunity for Stanford assistant professors and associate professors (within the first few years of their appointment) with PI eligibility (UTL, MCL, and NTLR appts) and CE assistant and associate professors (with an approved CE faculty PI waiver). Senior investigators (full professors with PI eligibility or CE full professors with an approved CE faculty waiver) can submit an internal proposal if the project represents a new direction for them (see eligibility >>)

Funding of up to $200,000 payable over three years is provided for proposed neuroimaging studies undertaken by promising early career investigators who have not yet been awarded more than one independent research grant (R01 from the NIH or equivalent from another Federal agency).


The 2018 internal selection process has been completed. This webpage is for your reference only.


# of applicants: 1 applicant (preliminary proposal) is permitted (see internal submission guidelines)

Internal Stanford Neuroscience Institute deadline: Jan. 16, 2018, 5 p.m. (see internal submission guidelines below)
Date applicant notified of their selection by SNI: Jan. 23, 2018
The applicant selected will be given additonal instructions regarding the online submission and request for a DRAFT letter of support for Dean Minor to sign: Jan. 30, 2018
Sponsor's preliminary application deadline: February 5, 2018, 3 p.m. EST (online)
Applicants will be informed within eight weeks of the preliminary proposal deadline on whether they are invited to prepare full proposals.
First awards announced in Sept. 2018. Subsequent award notices will be made in December 2018.

Program overview webpage and links to previous recipients:
The following "How to apply" webpage is for your reference (see the internal submission guidelines below).
A PDF file of the guidelines can be downloaded from this webpage:
FAQ webpage:

Amount of funding:
Up to $200,000 total direct costs payable over 3yrs
The Foundation does not provide support for indirect costs. However, up to 10 percent of the total grant award may be used to purchase and maintain equipment needed for the study.  The balance is to be used to meet direct research costs. Research that can be supported through clinical income should not be submitted. Studies should be designed to obtain meaningful data withinthe grant award period of up to three years.


Imaging Categories:
The applicant selected to represent Stanford can be from either of the following categories or both.

The Dana Foundation’s Neuroimaging research program focuses on improving human brain and brain-immune functioning to promote health, and prevent and treat disease. Funds support pilot-testing by investigators, who are early in their research careers, to enable them to pursue promising, high-risk, and innovative ideas that have a direct clinical application. The pilot data are anticipated to help increase competitiveness for seeking larger-scale support from other funders.

The Program is designed to enable investigators to obtain pilot data more quickly than is possible through other funding processes.

This program, like all other Dana-supported research, is designed to improve human health. Investigations need to be applicable to human brain or brain-immune functioning or malfunctioning. To be considered for funding, submitted proposals should focus on imaging in patients or patient tissues, and healthy volunteers.

Applications for animal model studies of brain conditions or injuries will be considered only if they relate directly to
humans but cannot yet feasibly be undertaken in humans, and are anticipated to be translated into human research
following the three-year grant period. Such studies include research on:

General Areas of Interest
Previously funded studies under this Program have focused primarily on:

In addition to these three general areas of continued interest, it is becoming increasingly apparent that neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, and mental illnesses such as schizophrenia and depression start long before they are clinically evident. The Foundation, therefore, encourages studies that seek to understand developmental processes of disease, surrogate measures of early disease existence, and measures of disease progression.

Tips for applicants:

What they do not fund


By January 16, 2018, 5 p.m., please submit one PDF file containing the following in the order listed below to:

Roula El-Asmar
Program Manager
Stanford Neurosciences Institute

File name
: Last name_Dana_Fdn_Neuroimaging.pdf

You do NOT have to submit your internal proposal through RMG or OSR for approval. You can submit your internal proposal directly

Format (per the sponsor's guidelines): The proposal should be formatted using 11-point font, 0.5 inch margins in all directions with numbered pages. Applications using a smaller font size will not be reviewed.

1) Cover Page
The Dana Foundation David Mahoney Neuroimaging Program:
a. Principal Investigator information:
i. Project title;
ii. Principal investigator(s) name(s) and degree(s);
iii. Title(s);
iv. Phone and fax numbers;
v. E-mail; and
vi. Street address(es).
b. Indicate the imaging category (structural/physiological or cellular/molecular, or a combination of both)
specify the imaging technique(s) to be used (such as fMRI, two-photon, etc.).

Preliminary proposal (two pages):
The following five sections should total no more than two pages (including figures).

(These are based on the sponsor’s preliminary proposal guidelines.)
Include as a header for each page:
Your full name and Stanford University School of Medicine
a. Section I: A clearly and succinctly stated hypothesis.
b. Section II: The aims of the proposed research project. What disease(s), disorder(s) or injuries would be
better understood, diagnosed, or treated? Or, what normal brain function or brain-immune interaction
would be better understood? Or, what imaging technology would be refined and for what specific
purposes? Such technology development or modification aims need to be accompanied by initial evidence
of the project’s feasibility.
c. Section III: The research significance and potential clinical application(s) of the research.
d. Section IV: The methods. Please clearly describe the research design and specify tests and analyses
proposed to develop the pilot data. If enrollment of human participants is planned, please provide
preliminary evidence that the number required can be recruited from the participating institution(s).
e. Section V: The qualifications of the primary investigator(s) for undertaking the proposed research. What
facilities and resources at the applicant institution(s) would be used in the research? Please provide
evidence that required technologies would be available for this project.
Include a header with your" full name and Stanford University School of Medicine” and the name of the respective "Appendix” for each page:
4) Appendix A
A list of all active grants and pending proposals by the applicant(s). Please include an abstract that
specifies the aims for any existing or pending grants from these sources of support that are related to, or could
potentially overlap with, the proposed Dana study.
5) Appendix B: Please provide a standard NIH format CV for the primary investigator(s).
6) Appendix C: You may include up to two additional pages to list relevant references. Please bold the name of the
primary investigator(s) where it appears in the references.

(Note: 7. Appendix D: Optional: High resolution photographs that support the methodology proposed. (The applicant selected will have an opportunity to submit these to the sponsor. Please do not submit photographs for the internal selection process.)

Selection process

Your proposals will be reviewed by the Stanford Neuroscience Institute Advisory Committee. The final applicant selected will be given additional instructions (including preparing a draft letter of support for Dr. Minor's signature.



Footer Links: